{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:52:07Z","timestamp":1791409927675,"version":"4.3.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008770","name":"Anadolu University","doi-asserted-by":"publisher","award":["2301S002"],"award-info":[{"award-number":["2301S002"]}],"id":[{"id":"10.13039\/501100008770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110369","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:39:49Z","timestamp":1786491589000},"page":"110369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of thiazole-hydrazone hybrids for targeted therapy of non-small cell lung cancer"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8159-663X","authenticated-orcid":false,"given":"Mehlika Dilek","family":"Alt\u0131ntop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-4157","authenticated-orcid":false,"given":"\u0130pek","family":"Ertorun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9535-2508","authenticated-orcid":false,"given":"G\u00fcl\u015fen","family":"Akal\u0131n \u00c7ift\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-5550","authenticated-orcid":false,"given":"Ahmet","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110369_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bioorg.2026.110369_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/ijms17040494","article-title":"Diagnosing lung cancers through examination of micro-RNA biomarkers in blood, plasma, serum and sputum: a review and summary of current literature","volume":"17","author":"Gyoba","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110369_bb0015","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2174\/1389450115666140528151649","article-title":"Non-small cell lung carcinoma: an overview on targeted therapy","volume":"16","author":"Nascimento","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2026.110369_bb0020","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/ijms17060839","article-title":"Targeting DNA damage response in the radio(chemo)therapy of non-small cell lung cancer","volume":"17","author":"Li","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110369_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","article-title":"Recent advances in therapeutic strategies for non-small cell lung cancer","volume":"18","author":"Su","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110369_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer","volume":"169","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110369_bb0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12032-022-01744-6","article-title":"A pharmacological exploration of targeted drug therapy in non-small cell lung cancer","volume":"39","author":"Jayan","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bioorg.2026.110369_bb0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","article-title":"EGFR signaling pathway as therapeutic target in human cancers","volume":"85","author":"Levantini","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2026.110369_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118135","article-title":"Overcoming EGFR mutation resistance: dual inhibition strategies using TKIs in non-small cell lung cancer therapy","volume":"300","author":"Sivam","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100076","article-title":"Cracking the EGFR code: Cancer biology, resistance mechanisms, and future therapeutic frontiers","volume":"77","author":"Du","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2026.110369_bb0055","article-title":"The mechanism of AKT activation in cancer","volume":"1","author":"Meng","year":"2025","journal-title":"Cell Investig."},{"key":"10.1016\/j.bioorg.2026.110369_bb0060","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3892\/ijo.2015.3306","article-title":"Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use (review)","volume":"48","author":"Nitulescu","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2026.110369_bb0065","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/09298673113209990106","article-title":"Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells","volume":"20","author":"Cassinelli","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42826-019-0030-0","article-title":"Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad","volume":"35","author":"Kang","year":"2019","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.bioorg.2026.110369_bb0075","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0080","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.3390\/cancers13246228","article-title":"Multicellular effects of STAT3 in non-small cell lung cancer: mechanistic insights and therapeutic opportunities","volume":"13","author":"Parakh","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.110369_bb0085","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.3390\/molecules26113166","article-title":"Thiazole ring-a biologically active scaffold","volume":"26","author":"Petrou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110369_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112016","article-title":"Thiazole-containing compounds as therapeutic targets for cancer therapy","volume":"188","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115172","article-title":"Application and synthesis of thiazole ring in clinically approved drugs","volume":"250","author":"Niu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114661","article-title":"New thiazole-based derivatives as EGFR\/HER2 and DHFR inhibitors: synthesis, molecular modeling simulations and anticancer activity","volume":"241","author":"Sabry","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0105","doi-asserted-by":"crossref","first-page":"17471","DOI":"10.1074\/jbc.RA119.009801","article-title":"A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3","volume":"294","author":"Shen","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116698","article-title":"Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy","volume":"276","author":"Alt\u0131ntop","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118305","article-title":"Anticancer activity of hydrazones in the last quinquennial period: a special emphasis on various enzyme targets and SAR","volume":"302","author":"Charan","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138012","article-title":"Hydrazide-hydrazone\/hydrazone as enabling linkers in anti-cancer drug discovery: a comprehensive review","volume":"1307","author":"Murugappan","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110369_bb0125","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/ph18071051","article-title":"Purine-hydrazone scaffolds as potential dual EGFR\/HER2 inhibitors","volume":"18","author":"Albalawi","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110369_bb0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ddr.22022","article-title":"A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer","volume":"84","author":"Orujova","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110369_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105684","article-title":"Novel sulfonyl thiazolyl-hydrazone derivatives as EGFR inhibitors: design, synthesis, biological evaluation and molecular docking studies","volume":"121","author":"Farghaly","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.110112","article-title":"Vatansever, Discovery of new thiazolyl hydrazone derivatives as anti-breast cancer agents: synthesis, biological evaluation and in silico studies","volume":"180","author":"Tok","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109938","article-title":"Development of a new series of thiazoles as EGFR-targeted anticancer agents for NSCLC therapy through nanotechnological and computer-aided approaches","volume":"178","author":"Alt\u0131ntop","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejmech.2015.09.009","article-title":"Novel 3,4-methylenedioxyde-6-X-benzaldehyde-thiosemicarbazones: synthesis and antileishmanial effects against Leishmania amazonensis","volume":"103","author":"de Melos","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0022-2860(02)00564-1","article-title":"Structural studies and spectral characteristics of 4-benzoylpyridine thiosemicarbazone and N(4\u02c8)-phenyl-4-benzoylpyridine thiosemicarbazone","volume":"645","author":"Beraldo","year":"2003","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110369_bb0160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molstruc.2015.03.011","article-title":"Intermolecular interaction of thiosemicarbazone derivatives to solvents and a potential Aedes aegypti target","volume":"1093","author":"da Silva","year":"2015","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110369_bb0165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10856-025-06951-x","article-title":"A review of cytotoxicity testing methods and in vitro study of biodegradable Mg-1%Sn-2%HA composite by elution method","volume":"36","author":"Jhamb","year":"2025","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.bioorg.2026.110369_bb0170","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110369_bb0175","doi-asserted-by":"crossref","first-page":"22366","DOI":"10.1021\/acs.jmedchem.5c01314","article-title":"Nitro-substituted benzylic organochalcogenides as anticancer agents: unravelling the multifaceted pathways to combat triple-negative breast cancer","volume":"68","author":"Barman","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110369_bb0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/ph15020187","article-title":"Nitroaromatic hypoxia-activated prodrugs for cancer therapy","volume":"15","author":"Denny","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110369_bb0185","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110369_bb0190","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10495-022-01735-y","article-title":"Programmed cell death detection methods: a systematic review and a categorical comparison","volume":"27","author":"Kari","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2026.110369_bb0195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2026.110369_bb0200","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nm1263","article-title":"Caspase-independent cell death","volume":"11","author":"Kroemer","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110369_bb0205","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/ijc.34288","article-title":"Out of the cycle: impact of cell cycle aberrations on cancer metabolism and metastasis","volume":"152","author":"Cheung","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.110369_bb0210","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ceb.2004.09.014","article-title":"Targeting cell cycle and apoptosis for the treatment of human malignancies","volume":"16","author":"Senderowicz","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110369_bb0215","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/ph13110374","article-title":"Current targeted therapies for the fight against non-small cell lung cancer","volume":"13","author":"Mustachio","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110369_bb0220","doi-asserted-by":"crossref","first-page":"0098","DOI":"10.34133\/hds.0098","article-title":"Current trends and challenges in drug-likeness prediction: are they generalizable and interpretable?","volume":"3","author":"Zhu","year":"2023","journal-title":"Health Data Sci."},{"key":"10.1016\/j.bioorg.2026.110369_bb0225","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ardp.200600200","article-title":"Synthesis and antibacterial activity of tert-butyl [1-benzyl-2[(4-aryl-2-thiazolyl)hydrazono]ethyl]carbamate derivatives","volume":"340","author":"Turan-Zitouni","year":"2007","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.bioorg.2026.110369_bb0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.110369_bb0235","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:18:13Z","timestamp":1791407893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S0045206826009053"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110369","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of thiazole-hydrazone hybrids for targeted therapy of non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110369"}}